Clinical Trials Logo

Advanced Stage Solid Tumors clinical trials

View clinical trials related to Advanced Stage Solid Tumors.

Filter by:
  • None
  • Page 1

NCT ID: NCT06255665 Recruiting - Clinical trials for Advanced Stage Solid Tumors

A Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid Tumors

Start date: February 9, 2024
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine recommended phase 2 dose(s) (RP2Ds) of JNJ-79032421 and to determine the safety and tolerability of JNJ-79032421 at the RP2D(s).

NCT ID: NCT03309150 Active, not recruiting - Clinical trials for Advanced Stage Solid Tumors

ATRi Transition Rollover Study

Start date: January 10, 2018
Phase: Phase 1
Study type: Interventional

The main purpose of the study is to monitor the safety of participant receiving long-term treatment of M6620 as monotherapy or in combination with carboplatin and paclitaxel.

NCT ID: NCT02160106 Completed - Clinical trials for Advanced Stage Solid Tumors

First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors

Start date: July 29, 2014
Phase: Phase 1
Study type: Interventional

The phase I dose escalation study will investigate the safety, tolerability, and pharmacokinetics of the TGF-β pathway inhibitor TEW 7197 in subjects with advanced, refractory solid tumors.